Patents by Inventor Beth Goins

Beth Goins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8916197
    Abstract: The present invention pertains to a bone marrow-directing drug delivery material that includes at least one fine particle, wherein the fine particle includes an anionic moiety on a surface of the particle. Also disclosed are uses of the material set forth herein for the prevention, treatment, or diagnosis of a disease of bone, cartilage, bone marrow, or a joint. Also disclosed are methods of preventing, treating, or diagnosing a disease of bone, cartilage, bone marrow, or a joint in a subject, involving administering to the subject a pharmaceutically effective amount of the material of the present invention.
    Type: Grant
    Filed: June 5, 2006
    Date of Patent: December 23, 2014
    Assignees: The Board of Regents of the University of Texas System, Waseda University
    Inventors: Keitaro Sou, Shinji Takeoka, Eishun Tsuchida, Beth A. Goins, William T. Phillips
  • Patent number: 7718160
    Abstract: The invention, in one aspect, relates to radiolabeled compounds. The invention also relates to radiolabeled liposomes and methods of making and using thereof. The invention also relates to kits for preparing radiolabeled liposomes.
    Type: Grant
    Filed: May 22, 2003
    Date of Patent: May 18, 2010
    Assignee: The Board of Regents of the University of Texas System
    Inventors: Ande Bao, William T. Phillips, Beth Goins
  • Publication number: 20090297608
    Abstract: The present invention pertains to a bone marrow-directing drug delivery material that includes at least one fine particle, wherein the fine particle includes an anionic moiety on a surface of the particle. Also disclosed are uses of the material set forth herein for the prevention, treatment, or diagnosis of a disease of bone, cartilage, bone marrow, or a joint. Also disclosed are methods of preventing, treating, or diagnosing a disease of bone, cartilage, bone marrow, or a joint in a subject, involving administering to the subject a pharmaceutically effective amount of the material of the present invention.
    Type: Application
    Filed: June 5, 2006
    Publication date: December 3, 2009
    Inventors: Keitaro Sou, Shinji Takeoka, Eishun Tsuchida, Beth A. Goins, William T. Phillips
  • Publication number: 20070003607
    Abstract: The disclosed matter relates to neutral liposomes containing an encapsulated compound and post-insertion compound. Also described herein are methods of making and using the neutral liposomes.
    Type: Application
    Filed: August 27, 2004
    Publication date: January 4, 2007
    Inventors: Vibhudutta Awasthi, William Phillips, Beth Goins
  • Patent number: 7060689
    Abstract: The present invention is directed to delivery and retention of active agents to targeted lymph nodes in a mammal using a ligand/anti-ligand pair. More particularly, the invention involves methods, compositions, and kits for delivery and retention of active agents to targeted lymph nodes using compositions comprising a ligand-colloid moiety and compositions comprising an anti-ligand. Active agents may be associated with one or more of the colloid, ligand, or anti-ligand. Conjugation of the ligand and anti-ligand after administration permits retention of aggregated colloid complex in targeted lymph nodes.
    Type: Grant
    Filed: January 11, 2002
    Date of Patent: June 13, 2006
    Assignee: The Board of Regents of the University of Texas System
    Inventors: Beth A. Goins, William T. Phillips
  • Publication number: 20020164648
    Abstract: The present invention is directed to delivery and retention of active agents to targeted lymph nodes in a mammal using a ligand/anti-ligand pair. More particularly, the invention involves methods, compositions, and kits for delivery and retention of active agents to targeted lymph nodes using compositions comprising a ligand-colloid moiety and compositions comprising an anti-ligand. Active agents may be associated with one or more of the colloid, ligand, or anti-ligand. Conjugation of the ligand and anti-ligand after administration permits retention of aggregated colloid complex in targeted lymph nodes.
    Type: Application
    Filed: January 14, 2002
    Publication date: November 7, 2002
    Applicant: Board of Regents, The University of Texas System
    Inventors: Beth A. Goins, William T. Phillips